Regarding the pathophysiological context, our findings are particularly relevant to Notch-driven leukemias, T-cell acute lymphoblastic leukemia (T-ALL), and chronic lymphocytic leukemia (CLL), for which NOTCH1 mutations have been previously described [56, 57]. This evidence concerns the gene NOTCH1 and leukemia.